The main regulator of pIP501 replication is an antisense RNA (RNAIII) 
Introduction
Antisense RNAs are the principal copy number control elements of many plasmids (Wagner & Simons, 1994) . In all cases, RNA/RNA binding seems to be the key event, with binding kinetics and intracellular RNA concentrations as the determinants of inhibition of sense RNA function and, hence, the replication frequency. The mechanism by which RNA/RNA interaction inhibits replication can, however, differ: inhibition of primer formation (Tomizawa, 1986) , inibition of Rep protein synthesis through prevention of leader peptide translation (Blomberg et al., 1992; Wu et al., 1992) , inhibition of pseudoknot formation that is required for Rep synthesis (Asano et al., 1991; Wilson et al., 1993) or induction of premature termination (attenuation) of a rep mRNA (Novick et al., 1989; Brantl et al., 1993 ). An interesting phenomenon, possibly specific for antisense RNA-controlled plasmids in Gram-positive bacteria, is that deletion or inactivation of the antisense RNA gene fails to result in runaway replication (Kumar & Novick, 1985; . This is different from the situation in Gram-negative hosts (Uhlin & Nordströ m, 1978) . Thus, a comparative study of the streptococcal plasmid pIP501 with plasmids like R1 or ColE1 may illustrate similarities in mechanism as well as metabolic peculiarities of two classes of bacterial hosts.
Replication of the broad host range plasmid pIP501 (Horodniceanu et al., 1976 ) is controlled at the initiation of transcription by CopR (Brantl, 1994) and post-transcriptionally by an antisense RNA (RNAIII: Brantl et al., 1993: and see Figure 1 ). RNAIII induces transcriptional attenuation of RNAII comprising the repR mRNA and its leader region. Transcriptional attenuation has been studied in vitro, and pairing rate constants and inhibition rate constants of wild-type and truncated RNAIII species have been determined (Brantl & Wagner, 1994) . The inhibition rate constant of RNAIII-induced RNAII termination was 1 × 10 6 M −1 s −1 , i.e. ten times higher than the pairing rate constant for the same RNA pair. We therefore concluded that steps preceding stable antisense/target RNA pairing are sufficient to induce termination of nascent RNAII transcripts. However, to understand the quantitative aspects of control in vivo, it is necessary to know the steady-state concentrations of sense and antisense RNAs. Whereas for the Escherichia coli plasmid ColE1, Brenner & Tomizawa (1991) have quantified the intracellular amounts of sense and antisense RNA, no similar analysis has been performed for any antisense RNA-controlled plasmid replicating in Gram-positive bacteria. Furthermore, mutations that affect inhibitor/target RNA interaction are poorly understood for the latter plasmids. No mutation has been shown to explicitly affect inhibitor/target binding in vitro. Previously, we constructed several pIP501 derivatives with defined nucleotide changes in the computer-predicted stem-loop structures of RNAIII and RNAII. These mutants showed the expected copy number increase (Brantl et al., 1993) . Secondary structure probing in vitro allowed correction of the computergenerated structure of both RNAs (Brantl & Wagner, 1994) and located some of the mutations within these structures. Furthermore, we showed in vitro that only certain segments of RNAIII are required for stable pairing and inhibition. A combination of in vitro and in vivo analyses of the mutant RNAs should now allow an understanding of the basis of the mutants and improve our current knowledge of the control circuit of wild-type pIP501.
Here, intracellular concentrations and half-lives of RNAII and RNAIII were measured. The results suggest a dual function for CopR (see Discussion). Furthermore, four of the previously constructed mutants were characterized in detail both in vitro and in vivo. The mutants fall into two classes: (1) interaction mutants suggesting a key function for loop LIII of RNAIII as recognition loop; and (2) half-life mutants where the drastically reduced intracellular concentration of RNAIII is responsible for the copy number increase.
Results

Copy number control versus half-life of wild-type sense and antisense RNAs
Steady-state concentration of RNAIII in vivo
To calculate the amount of RNAIII or RNAII within one Bacillus subtilis cell carrying a pIP501 derivative, several points have to be taken into account. Firstly, a reference RNA of defined concentration is required. Secondly, losses during the RNA isolation procedure have to be estimated. Thirdly, loading errors have to be corrected to assure that the same amounts of total RNA are compared. Fourthly, the cell titer of the culture has to be determined.
To Figure 2A ). To calculate the loss during the RNA isolation procedure, standard RNA was mixed with plasmid-free DB104 at the beginning of the RNA preparation. A comparison with the same amounts of untreated RNAIII yielded about 80% loss ( Figure 2B ). Loading errors were corrected by reprobing with labelled oligonucleotide C767-27 as described in Materials and Methods. To minimize quantification errors, total RNA was isolated in parallel from four samples of 1.5 ml cultures, the cell titer of which was determined by plating different dilutions on TY agar. The copy number/ chromosome of pCOP4 and pPR1 was determined previously to be between five and ten (Brantl et al., 1993) and 50 to 100 , respectively.
Using this quantification procedure, the amount of RNAIII WT within one B. subtilis cell carrying a pBT48 (Brantl et al., 1990) , carrying the complete replication region of pIP501, Pm R Brantl & Behnke (1992) pPR1 pCOP4 derivative lacking the copR sequence upstream of the KpnI site Brantl et al. (1993) pPR347 pPR1 derivative carrying two point mutations a (G347-A, additional A between nt 345 and nt 346) Brantl et al. (1993) pPR382 pPR1 derivative carrying two point mutations (G382-A, T388-C) pPR383 Brantl et al. (1993) pPR1 derivative carrying two point mutations (G383-A, A416-G) Brantl et al. (1993) pPR408 pPR1 derivative carrying a point mutation (G408-A) R. Breitling, unpublished pGK14 pGK13 (Kok et al., 1984) pIP501 derivative was calculated to be 1000 to 2000 molecules. This is estimated to correspond to an approximate intracellular concentration of 1.4 × 10 −6 to 2.8 × 10 −6 M. Surprisingly, these RNAIII concentrations were found for both pPR1 (copR deletion derivative) and pCOP4 (wild-type plasmid).
Steady-state concentration of RNAII in vivo
On the basis of previous in vivo and in vitro experiments, we expect at least two species of RNAII within a B. subtilis cell: attenuated RNAII (RNAII T ; 260 nt) and full-length RNAII (RNAII F ; about 1900 nt). To calculate the amount of RNAII T / cell, the same approach as for RNAIII was applied except that defined amounts of [ 3 H]UTP-labelled RNAII 183 synthesized in vitro were used as standard and hybridization was performed with [a-32 P]UTPlabelled RNAIII. For pCOP4, representing the wild-type situation, an average amount of 50 molecules of RNAII T /cell was calculated, whereas for pPR1 lacking copR about 1000 molecules of RNAII T were estimated ( Figure 2B ). The amount of attenuated RNAII seems to correlate directly with the copy number of the corresponding plasmids.
Initial Northern blot experiments to estimate the amount of RNAII F using 1% (w/v) agarose gels for the separation of glyoxylated total RNA failed. Apparently, these long RNA species are rapidly degraded (see below), and nascent RNAII molecules vary widely in length, making an unambiguous determination very difficult. To circumvent these problems, a lysate ribonuclease protection kit was used. Total RNA isolated from 1 ml of DB104(pPR1) was hybridized with [ 32 P]UTPlabelled RNA 168 as described in Materials and Methods, and subsequently digested with RNases. Defined amounts of in vitro synthesized [ 3 H]UTPlabelled RNAII 500 were treated in parallel as a standard for calculations. Protected fragments of all sizes between 1 nt and the expected 148 nt, confirming the variation of the length of nascent RNAII molecules, were found (not shown). Quantification of all species in comparison with the standard RNAII 500 yielded about 800 molecules RNAII F /cell, i.e. nearly the same amount as found for RNAII T . Due to the high variation of the length of the protected fragments, the signals were very weak and made both the determination of the half-life of RNAII F and a similar quantification for RNAII F transcribed from the low copy plasmid pCOP4 not feasible.
Half-life of RNAIII in vivo
To determine the half-life of RNAIII WT , rifampicin experiments were performed with DB104(pGKIII/ 1) as described in Materials and Methods. Samples were taken at the times indicated and, as controls, two aliquots were taken from cultures without rifampicin at 0 and 60 minutes ( Figure 4A ). Quantification of the decay of RNAIII, corrected for loading, is depicted in Figure 4C . From the slope of lin-log plots the half-life of RNAIII was calculated to be about 30 minutes ( Figure 4C ).
Half-life of RNAII in vivo
The half-life of (RNAII T ) was determined using DB104(pPR1) and DB104(pGTW) following the same procedure as for RNAIII except that after pilot experiments, a different time-scale was chosen ( Figure 4B ). The graph in Figure 4D represents the determined, corrected band intensities, and yielded a half-life of about one minute for the attenuated RNAII T . For the full-length RNAII (RNAII F ; ca 1.9 kb) the half-life could neither be determined using an agarose gel nor using the RNase protection assay (see above). Therefore, our calculation was based on the half-life of the major RNAII F species transcribed from pGTW (360 nt), which was found to be in the same range as that of RNAII T .
Characterization of stem-loop mutants of RNAII/RNAIII
Recently, a series of pIP501 mutants altered in the RNAII/RNAIII region were constructed that showed a significant copy number increase (Brantl et al., 1993) . This copy number effect could be primarily due to altered binding/inhibition kinetics, altered intracellular RNAIII concentration, or both. Four previously constructed pIP501 mutants were chosen for the present study: pCOP347 and pCOP383 replicating at five-to tenfold elevated copy number, and pCOP382 and pCOP408 showing a ten-to 20-fold copy number increase. In the case of pCOP347, pCOP382 and pCOP383, repeated sequencing in the course of this study has shown that PCR used to generate the mutants had introduced a second mutation, so that for these plasmids the copy-up phenotype is the result of two mutations. The location of all mutations is indicated in Figure 3 .
Enzymatic probing of the mutant RNAIII variants was performed in vitro as described (Brantl & Wagner, 1994) , and largely confirmed that the overall structures were conserved (data not shown), except that mutant RNAIII 408 showed a somewhat higher accessibility to RNAse T 1 in the unstructured middle region.
Half-life of mutant RNAIII species
The same approach as that used for RNAIII WT was applied to determine the half-life of mutant RNAs in B. subtilis. Autoradiograms of the gels used for quantification are shown in Figure 5 . A comparison of the half-lives of wild-type and mutant RNAIII species (Table 2) shows that the half-life of RNAIII 408 was severely decreased to about two minutes, whereas the half-lives of RNAIII 347 , RNAIII 382 and RNAIII 383 were decreased, only slightly, at 15 to 20 minutes.
Binding rates of mutant RNAIII species in vitro
Antisense/target RNA pairing was analysed in vitro as described (Brantl & Wagner, 1994) . Both mutant/mutant and mutant/wild-type RNA pairs were investigated. Table 3 shows the determined pairing rate constants (k app ). Interestingly, k app values of mutant/mutant pairs were of the same order of magnitude as those of the wild-type/wild-type pair. However, when binding between RNAII WT Half-lives were determined as described in Materials and Methods. Northern blots are shown. Samples were taken at the indicated times after rifampicin addition or without rifampicin at time-point 0 and at the end. Hybridization was with labelled RNAII. M, pBR322 HinfI size marker. In all cases, reprobing to correct loading errors was performed as described in Materials and Methods (data not shown). In E, decay kinetics are graphically summarized. and mutant RNAIII species was analysed, significant differences between the single mutants were observed. Whereas RNAIII 408 
Incompatibility
To analyse whether the mutations resulted in compatibility, i.e. whether the mutated RNAIII had lost its inhibitory activity towards the wild-type target, wild-type and mutant RNAIII species were provided in trans from the pIP501-compatible plasmid pUCB1 (50 to 100 copies). Each of the resulting plasmids pCBW, pCB347, pCB382, pCB383 and pCB408 was transformed into DB104 containing Incompatibility was tested as described in Materials and Methods using plasmid pGB534 as source for wild-type RNAII and plasmids pCBW, and pCB347, pCB382, pCB383 and pCB408, as sources for RNAIII. +++, Resident plasmid was displaced immediately after transformation; +, resident plasmid was displaced; −, resident plasmid was not displaced even after cultivation for about 100 generations.
a Single heteroplasmid strains varied widely in loss frequency of the resident plasmid pGB354. the pIP501 derivative pGB354 (50 to 100 copies). Incompatibility was tested as described in Materials and Methods, and the results are shown in Table 4 . Wild-type plasmid pCBW and mutant plasmid pCB347 displaced pGB354 during an overnight cultivation (strong incompatibility), whereas pGB354 could stably coexist with both pCB382 and pCB383 over about 100 generations, indicating full compatibility. Plasmid pCB408 showed an intermediate phenotype, and single heteroplasmid strains carrying pGB354 and pCB408 varied widely in their behavior. With the exception of the latter plasmid, the results of the incompatibility tests correlated well with the pairing rate constants determined for RNAII WT /mutant RNAIII pairs.
Effect of the mutations on the attenuation pattern in vivo
To analyse attenuation in vivo, plasmid pGT1 was used to insert wild-type and mutant fragments of the pIP501 replication region comprising pII, pIII, the attenuator IR2 and 100 bp downstream of IR2, upstream of a transcriptional terminator T1. The resulting plasmids pGTW, pGT347, pGT382, pGT383 and pGT408 were transformed into DB104, total RNA was isolated and subjected to Northern blotting. Hybridization with labelled RNAIII allowed us to visualize two major RNAII species: attenuated RNAII T (260 nt) terminated at IR2 and ''full-length'' RNAII F (360 nt) terminated at T1. Both RNA species are comparable with those analysed in previous experiments in vitro (Brantl & Wagner, 1994) . Incomplete termination at T1 results in two longer minor RNA species ( Figure 6 ). All RNAII species were quantified in the PhosphorImager, and the percentage of RNAII T compared with the total amount of RNAII F (sum of the major and the two minor species) and RNAII T (%termination) was calculated. The results are shown in Table 5 . Whereas in the case of RNAII WT about 46% of all transcripts terminate at IR2, only between 2.7 and 10.8% termination were calculated for the mutant RNAII species coinciding with the elevated copy number of the corresponding pIP501 derivatives. Figure 6 . In vivo attenuation pattern of wild type and mutant RNAII species. Northern blot. A shows RNAII after hybridization with labelled RNAIII: RNAIIF, major band of full-length RNAII (360 nt: the two minor bands above result from incomplete termination and have been included into the calculation); RNAIIT, terminated RNAII. B, RNAIII species after reprobing with labelled RNAII. 1, pGTW; 2, pGT347; 3, pGT382; 4, pGT383; 5; pGT408; 6; pGTC4; M, pBR322 HinfI size marker. Termination was calculated as %T from F + T, where T is terminated RNAII (260 nt) and F is full-length RNAII (sum of three species; one major (360 nt) and two minor ( > 360 nt) species). The calculation is based on quantification of two independent gels run with total RNA samples isolated from independent cultures. T and F of each lane were calculated separately, and for each gel the average amount of termination was estimated from two or three parallel lanes. Figure 6A shows the autoradiogram of a corresponding gel. Figure 7 . Inhibition test. The inhibition test was performed as described in Results. The Northern blot is represented. A, RNAII after hybridization with labelled RNAIII: RNAIIF, full-length RNAII (major band (360 nt) and two minor bands above resulting from incomplete termination were included into the calculation); RNAIIT, terminated RNAII (260 nt). 1, pGTW; 2, pGTW + pCBW; 3, pGTW + pCB347; 4, pGTW + pCB382; 5, pGTW + pCB383; 6, pGTW + pCB408; B, the corresponding total amount of RNAIII (RNAIII expressed from pGTW + mutant RNAIII species) after reprobing with labelled RNAII.
Effect of the mutations in RNAIII on inhibition of a wild-type target RNA in vivo
Since pGTW does not depend on RNAII to replicate in B. subtilis, but contains the leader region of RNAII as target for the action of RNAIII, it can be used to investigate the ability of wildtype and mutant RNAIII species to induce termination of RNAII WT transcription in vivo. This protocol tests the effectiveness of a mutant RNAIII in inducing premature target RNA termination dependent on both target binding and antisense RNA concentration (i.e. half-life). Therefore, plasmids pCBW, pCB347, pCB382, pCB383 and pCB408 were transformed into DB104 (pGTW), and transformants were selected for resistance to erythromycin and kanamycin to ensure the maintenance of both plasmids. Total RNA was isolated from all heteroplasmid strains and from DB104(pGTW) as internal control and subjected to Northern blotting. Hybridization was performed with labelled RNAIII to visualize the attenuation pattern. Figure 7A shows the Northern blot, and Table 6 contains the results of the quantification. Both RNAIII WT and RNAIII 347 supplied in trans induced almost complete termination of RNAII transcription, i.e. no RNAII F could be detected. For RNAIII 382 and RNAIII 383 , about 35% termination were calculated, whereas for RNAIII 408 no alteration of the attenuation pattern compared with that of pGTW (this gel: 30.5% termination) was found. A comparison of the detectable amounts of total RNAIII indicates that pCBW, pCB347, pCB382 and pCB383 supplied 13 to 83-fold excess of RNAIII, whereas pCB408 supplied only 0.7-fold excess additionally to RNAIII WT expressed from pGTW ( Figure 7B ). For pCB408, the extremely short half-life of RNAIII 408 (only two minutes) seems to prevent the accumulation of higher additional amounts of RNAIII. With the exception of the latter RNAIII, inhibition observed in vivo coincides well with the results of the incompatibility analysis.
Discussion
We present a quantitative analysis of the antisense (RNAIII) and sense (RNAII) RNAs encoded by plasmid pIP501. Signals corresponding to RNAIII and relevant RNAII species were measured by Northern blot analysis, and the number of RNA molecules was determined using defined amounts of in vitro synthesized RNAs as standards. In vivo and in vitro tests were performed to characterize antisense RNA-mediated attenuation with wildtype and mutant RNAIII. From the experiments reported above, two results were most striking and permit us to draw important conclusions regarding the regulation of pIP501 copy number. Firstly, RNAIII has an unusually long half-life of 130 minutes (Figure 4) , which is very unlike any other antisense RNA involved in plasmid copy number control reported so far. Secondly, in certain pIP501 derivatives that were previously suspected to be copy number mutants, the intracellular steady-state concentrations of antisense and target RNA were approximately equal (pPR1 [copR deletion], 11000 molecules RNAIII and RNAII per cell; Figure 2 ), RNAIII was supplied in trans to pGTW by pCBW, pCB347, pCB382, pCB383 and pCB408. Termination was calculated as for Table 5 . This table represents the separate quantification of parallel, separately prepared samples analyzed on the gel shown in Figure 7 . I, Left half of gel; II, right half of gel.
a Total amount of RNAIII (RNAIIIWT transcribed from pGTW plus RNAIII provided in trans) that was calculated in relation to the amount x expressed intrinsically from pGTW. which argues that under such conditions proper control is not possible.
Rapid and precise correction of deviating copy number requires that the replication probability is inversely related to the plasmid copy number. This is generally true for antisense RNA-regulated plasmid like, e.g. ColE1 (Eguchi et al., 1991) and R1 (Nordströ m and . These and other plasmids encode unstable antisense RNAs (halflives one to two minutes; Brenner & Tomizawa, 1991; unpublished results) . Rapid antisense RNA turnover ensures a proportionality between the concentrations of inhibitor and plasmid, i.e. the control circuit measures plasmid concentration in a short time-frame, and regulation of the replication frequency occurs accordingly. Here we show that the half-life of RNAIII is very long. This is predicted to result in instability of plasmid maintenance. If copy numbers fluctuate upwards, rapid synthesis of RNAIII will quickly adjust the antisense RNA concentration to the level that correlates with plasmid concentration, and replication will be more severely inhibited. In contrast, if the copy number fluctuates downwards, the intracellular concentration of RNAIII will, for an extended period of time, remain at the high level characteristic of the (previously) higher plasmid concentration. This implies that the replication frequency of the plasmids/cell-cycle becomes too low to restore the normal copy number. Thus, plasmid loss should occur at a significant rate. Since pIP501 is stably maintained (Janniére et al., 1990) , some mechanism must exist that counteracts this potential problem. We propose that the CopR protein provides such an activity.
CopR is a repressor of RNAII transcription (Brantl, 1994) , such that in the presence of this protein, tenfold less RNAII is synthesized than in its absence. The quantification of RNAIII in cells harboring pCOP4 and pPR1 (copR − ) showed essentially equal levels, even though gene dosage (copy number) was ten-to 20-fold different (Figure 2 ), whereas RNAII levels followed gene dosage as expected. This indicates that CopR either increases RNAIII half-life or interferes with RNAIII transcription. RNAIII half-lives were identical in the two strains tested (data not shown). Thus, CopR must affect transcription of RNAIII, either by activating initiation at the rnaIII promoter, or by preventing transcriptional interference of RNA polymerases transcribing through the rnaIII promoter region. Previous studies have excluded the first possibility (Brantl, 1994) . The second possibility is reminiscent of ''convergent transcription'' (in plasmid R1; Stougaard et al., 1982) . There, transcription from the repA promoter through the (antisense) copA promoter decreased CopA activity, and Blomberg et al. (1990 and unpublished results) showed that the level of CopA was decreased when repA mRNA transcription occurred. We propose that pIP501 employs a similar strategy, and a detailed analysis of this mechanism will be presented elsewhere.
The data presented here and by Brantl (1994) suggest that CopR plays a dual role: (1) it partially inhibits the synthesis of RNAII; and (2) it indirectly regulates the initiation frequency at the rnaIII promoter. We believe that this latter activity may explain how pIP501 can avoid the presumed deleterious effects of a stable antisense RNA. We recall that RNAIII alone should be able to compensate for increases in copy number, but that decreases were predicted to cause instability of maintenance. An intact copR gene should provide the function that re-establishes stability: when copy numbers drop, the rnaII promoter will become derepressed due to a decreased level of the repressor (Brantl, 1994) . The resulting increase in RNAII transcription will therefore increase the replication frequency. We propose that this increase of sense RNA transcription in addition decreases RNAIII synthesis (convergent transcription); i.e. a lower ratio of [RNAIII]/[plasmid] will cause a more rapid copy number increase. In conclusion, our model suggests that it is the combination of the two control functions CopR and RNAIII that permits pIP501 to cope with deviations in plasmid copy number to ensure stable maintenance, in spite of the long half-life of RNAIII.
The same transcription repressor function as that for CopR of pIP501 was found for CopF encoded by the closely related plasmid pAMb1 (Le Chatelier et al., 1994) . Previously, an antisense RNA of comparable length with 67.5% similarity to that of pIP501 was predicted to be transcribed from pAMb1 , and a secondary structure calculation yielded a similar secondary structure (unpublished results). It is, therefore, tempting to speculate that CopF could also play a dual role thereby compensating the effect of a presumably long half-life of the antisense RNA of pAMb1.
As reported previously ), a deletion of either rnaIII or copR results in a ten-to 20-fold copy number increase, but a double deletion failed to show additive effects. The analysis presented here indicates that mutation of either control gene can be sufficient to lead to loss of control: in the absence of CopR (pPR1, Figure 2 ) equal concentrations of RNAII and RNAIII were present. Homeostatic control requires that the regulator, the antisense RNA, is in significant excess over its target. Therefore, the highest copy numbers obtained in pIP501 (20-fold higher than for the wild-type plasmid) appear to be determined by a limitation in some host cell activity rather than by controlled, higher replication rate; i.e. at least the copR deletion mutant, but most likely also the rnaIII-mutants with the highest copy number effects, represent loss-of-control mutants rather than bona fide copy number mutants. If this is correct, it would be of interest to investigate what prevents plasmids like pIP501 and pT181 (the cop608 mutant plasmid completely lacks the gene for pT181s only control function, RNAI; Kumar & Novick, 1985) from runaway replication. An intriguing possibility is that Gram-positive hosts may carry enzymes that limit plasmid replication, whereas Gram-negative cells permit lethal overreplication of antisense RNA-regulated plasmids (Uhlin & Nordströ m, 1978) .
Recently, RNAIII-dependent attenuation of RNAII was assayed in vitro, and inhibition rate-constants were calculated to be 110 6 M −1 s −1 (Brantl & Wagner, 1994) . The pattern of RNAs generated in vitro showed that approximate half of the nascent transcripts terminated at the attenuator even in the absence of RNAIII. Here we show that intrinsic termination of RNAII at the attenuator sequence occurs in vivo as well (Tables 5 and 6 ; Figures 6 and 7) , and that RNAIII provided in high excess in trans completely prevents readthrough. Given a rough estimate of the intracellular concentration of RNAIII under these conditions of > 3 × 10 −6 M (see Results), a rate-constant of inhibition of 110 6 M −1 s −1 as determined by Brantl & Wagner (1994) in vitro is calculated to result in > 99% inhibition of readthrough, consistent with the observed value.
For several plasmids replicating in Gram-negative bacteria stem-loop mutant RNAs that caused elevated copy numbers were found to be correspondingly altered in their binding rates (Persson et al., 1988; Eguchi et al., 1991; Siemering et al., 1993 Siemering et al., , 1994 Sugiyama & Itoh, 1993) . In these systems pairing rate-constants are ca 1 × 10 6 M −1 s −1 , i.e. about one order of magnitude higher than those of RNAII/III of pIP501. Previously, we showed that in the case of pIP501 inhibition occurs much faster than stable pairing, indicating that steps preceding duplex formation are sufficient for the induction of termination (Brantl & Wagner, 1994) . For pIP501, mutant antisense/target RNA pairs did not differ significantly from their wild-type counterparts in pairing rates (Table 3) . However, mutant RNAIII species displayed altered binding kinetics with the heterologous wild-type target RNA: RNAIII 382 and RNAIII 383 mutated in loop LIII were essentially inactive in forming a duplex with RNAII WT , indicating a key role for LIII in recognition of the corresponding loop of the sense RNA. The results of the incompatibility (Table 4 ) and of inhibition experiments (ability of mutant RNAIIIs provided in trans to induce attenuation of RNAII; Table 6, Figure 7 ) support this hypothesis: RNAIII 382 and RNAIII 383 appear impaired in the recognition of RNAII WT . This lack of cross-reaction between these RNAs explains the fact that mutations in loop LIII result in new compatibility groups. In the inhibition experiment, RNAIII 382 and RNAIII 383 supplied in trans caused an increase in RNAII WT termination from 30.5% (terminated RNA in % of total RNAII, in the absence of RNAIII in trans; Table 6 ) to ca 35%. Considering the 13-to 28-fold molar excess of mutant RNAIII present, the small increase in inhibition confirms that the mutant RNAIII species are almost inactive on the wild-type target (cf. wild-type RNAIII; Table 6 ).
The plasmid constructs containing a terminator downstream of the pIP501 control region (pGT derivatives; Table 1 ) are maintained at a copy number that is independent of the pIP501 region, and were built to facilitate quantification of the attenuation pattern of RNAII. Changes in this pattern for pGT382 and pGT383 compared with the wild-type counterpart are determined by two factors: (1) the two-to threefold diminished half-lives of the mutant RNAIII species; and (2) the fact that loop LIII seems to play a key role in determining the pairing/inhibition rates. Thus, 10.8% and 7.5% termination were measured for RNAII 382 and RNAII 383 (Table 5 ) compared with 46% for RNAII WT . This correlates to about five-to tenfold elevated copy numbers of pCOP382 and pCOP383. This attenuation pattern does not quantitatively reflect the twofold difference in the copy numbers of these plasmids.
For RNAIII 347 , the results of the binding assay, inc test and inhibition test agree: RNAIII 347 can pair with RNAII WT (k app of 5 × 10 4 to 7 × 10 4 M −1 s −1 ; Table  3 ) and, therefore, causes complete incompatibility against wild-type pIP501. In the inhibition test, 83-fold excess of RNAIII 347 induced complete attenuation, like RNAIII WT (Table 6 ). The half-life of RNAIII 347 was somewhat reduced to 18 minutes, and binding between mutant RNAIII/II was about twofold slower, i.e. termination levels in vivo should be reduced. Figure 6 and 408 (1/15 of that of RNAIII WT ) results in very low intracellular concentrations, and therefore negligible activity is determined in the inc test (Table 3) , inhibition test (Figure 7 ; Table 6 ) and attenuation pattern (Figure 6 ; Table 5 ). It is possible that a destabilization of the unstructured middle region, as suggested by structure probing results, may contribute to the short half-life of RNAIII 408 . In the inhibition assay, pCB408 did not alter the attenuation pattern of pGTW, since the amount of RNAIII 408 supplied in trans was too small to significantly affect attenuation. The attenuation pattern of pGT408 showed a perfect correlation to the ten-to 20-fold increased copy number of pCOP408: only 2.7% termination of RNAII 408 transcription was calculated compared to 46% for the wild-type.
In summary, at least two classes of RNAII/ RNAIII mutants are found: half-life mutants (408) and interaction mutants (382; 383). Mutant 347 may represent a combination of both factors. The results obtained with 347 and 382/383 suggest that rate-limiting interactions between RNAII and RNAIII may initiate at loop LIII. While defects in LIII abolish the ability of an RNAIII species to interact with RNAII WT , defects in LIV may be less important. A larger collection of mutants with alterations in either of loops LIII or LIV will be helpful toward elucidating the binding process.
Materials and Methods
Bacterial strains, plasmids and growth conditions
Plasmids used in this study are listed in Table 1 . Plasmids were propagated in B. subtilis DB 104 (Kawamura & Doi, 1984) , and E. coli strain TG1 (Sambrook et al., 1989) was used for subcloning and mutagenesis. All strains were routinely grown at 37°C on tryptone-yeast (TY) medium. For the isolation of total RNA, DB104 transformants were cultivated on minimal medium containing spizizen salts (Anagnostopoulos & Spizizen, 1961) , 0.5% (w/v) glucose, 0.2% (w/v) Casamino acids and 5 mg/ml l-histidine.
DNA preparation and manipulation
DNA manipulations (restriction enzyme cleavage, ligation, phosphorylation, etc.) were carried out using conditions specified by the manufacturer or according to standard protocols (Sambrook et al., 1989) . A GenAmp PCR Kit from Perkin Elmer/Cetus was used for polymerase chain reactions (PCR). DNA sequencing was performed according to the dideoxy chain termination method (Sanger et al., 1977) with a Sequenase kit from US Biochemicals.
Construction of plasmids expressing wild-type and mutant rnaIII species
PCR was performed on a pUC119-F template with oligonucleotides C233-30 (5'GTC GAC GAA TTC ACA ACA AAA AAG GCA ATC) and C234-28 (5'GTC GAC GAA TTC AAC GAA CTG AAT AAA G). The resulting 260 bp fragment comprising rnaIII with IR2 was cleaved with EcoRI and inserted into the unique EcoRI site of plasmid pGK14 yielding plasmids pGKIII/1 and pGKIII/ 2 (either orientation). Plasmids pGK347, pGK382, pGK383 and pGK408 (insert orientation as in pGKIII/I) were constructed similarly except that plasmids pPR347, pPR382, pPR383 and pPR408 were used as templates for PCR.
To supply wild-type or mutant RNAIII in trans to pGK14-derived plasmids, a shuttle vector was constructed by cloning EcoRI-digested pUB110 into the unique EcoRI site of pUC18. Both orientations were obtained, pUCB1 and pUCB2. The unique PstI site of pUCB1 was used to insert wild-type and mutant rnaIII genes obtained as PCR fragments on either pUC119-F or pPR347, pPR382, pPR383 and pPR408 as templates (PCR-primers B1114-36 (5'GGA TCC GTC GAC TGC AGC ACA ACA AAA AAG GCA ATC) and B1115-36 (5'GGA TCC-GTC GAC TGC AGC AAC GAA CTG AAT AAA GAA)). Fragments were cleaved with PstI for insertion. For all rnaIII-encoding inserts both orientations were found by sequencing. The resulting recombinant plasmids were termed pCBW (wild-type), pCB347, pCB382, pCB383 and pCB408, respectively. Only plasmids with insert orientation 1 (RNAIII transcription in the same direction as repU transcription) were used in subsequent experiments.
Construction of plasmids for quantification of RNAIII and full-length and terminated RNAII
To achieve termination of RNAII transcription at a definite site, plasmid pGT1 was constructed containing a transcription terminator of the streptokinase operon. To this end, a 100 bp segment of plasmid pSU31 (Steiner & Malke, 1995) was amplified by PCR using the following primers: 5'AAG CTT GAA TTC GTC GAC TTC TAA AAC GAT GAG and 5'AAG CTT GAA TTC TAG TCT CTA CAA CTA AG. The EcoRI-digested fragment was cloned into the unique EcoRI site of pGK14. The insert orientation was confirmed by sequencing.
For the construction of pGTW, PCR was performed on pUC119-F using primers B 846-29 (5'GAA TTC GGA TCC AAC AGA ACC AGA ACC AG) and B 845-31 (5'GAA TTC GTC GAC CGT CAT GAA GCA CAG TTT C). The resulting 500 bp fragment encompassing pII/IR1 and pIII/IR2 was cleaved with BamHI and SalI, and inserted into pGT1 digested with the same enzymes. Plasmids pGT347, pGT382, pGT383 and pGT408 were obtained in the same way, using pPR347, pPR382, pPR383 and pPR408 as templates for PCR, respectively.
Plasmid pGTC4 comprising pI, pII/IR1 and pIII/IR2 was constructed by cloning a 1.16 kb BamHI/SalI-PCR fragment amplified on plasmid pCOP4 as template with primers B844-29 (5'TCT AGA GGA TCC AAA TTC CCA CTA AGC GC) and B 845-31 into the BamHI/SalI-digested pGT1 vector.
Test for incompatibility
To test whether wild-type and mutant RNAIII species confer incompatibility towards a pIP501 wild-type derivative, DB104(pGB354) was transformed with pCBW, pCB347/1, pCB382/1, pCB383/1 or pCB408/1. Transformants were selected on kanamycin (Km; for incoming plasmid): 70 transformants were streaked in parallel on TY agar plates containing either Km or chloramphenicol (Cm). Additionally, 12 transformants were grown overnight on TY with Km, and plasmids were isolated. In cases where both the resident and the incoming plasmid were detected, three selected heteroplasmid strains were cultivated for 1100 generations under selective pressure for the incoming plasmid only (TY + Km). After 12 generations each, aliquots were plated in parallel on TY, TY + Km and TY + Cm. To test for segregational loss of pGB354, DB104(pGB 354) was grown for 100 generations on TY without selective pressure, and aliquots were plated in parallel on TY with or without Cm. To confirm that the vector plasmid does not confer incompatibility towards pGB354, pUCB1 was transformed into DB104(pGB354) and analysed as above.
In vitro transcription
RNAII and RNAIII were synthesized in vitro by run-off transcription with phage T7 RNA polymerase from PCR-generated DNA templates as described (Brantl & Wagner, 1994 
In vitro binding assays
For binding reactions, [
3 H]UTP-labelled RNAII and [a-32 P]UTP-labelled RNAIII species were used and binding assays were performed as described (Brantl & Wagner, 1994) . Visualization and quantification of bands were performed on a Molecular Dynamics PhosphorImager, and autoradiograms were made from dried gels. Binding rate constants were calculated from slopes of linear-log plots, where the decrease in free, labelled RNA is measured as a function of time (Persson et al., 1988) .
Isolation of total RNA for Northern blot analyses
Overnight cultures of B. subtilis transformant strains were diluted 100-fold and grown on minimal medium. At A550 of 0.3 to 0.4, 1.5 ml of each culture was immediately frozen in liquid nitrogen. In cases, where RNA half-lives were analyzed, rifampicin was added (final concentration: 10 mg/ml) when A550 was 0.3 to 0.4. Samples were taken at the indicated time-points and immediately frozen in liquid nitrogen. Frozen samples were stored at −70°C for later preparation of total RNA. Centrifuged cells were suspended in 100 ml of lysis buffer 1 (100 mM NaCl, 50 mM EDTA, 10% (w/v) sucrose, 1 mg/ml lysozyme). After five minutes at 37°C, 300 ml of lysis buffer 2 (10 mM Tris-HCl (pH 7.5), 1 mM EDTA, 100 mM sodium acetate) was added, and one extraction with hot phenol (65°C) and two extractions with cold phenol/chloroform were performed. Supernatant was precipitated with 0.1 volume of sodium acetate 3 M (pH 7.0) and two volumes of ethanol. After centrifugation, the RNA was dissolved in 15 ml of water and stored at −20°C.
Northern blot analysis
For the analysis of RNAIII and shorter RNAII species, 5 ml of total RNA was denatured at 95°C with 5 ml of formamide loading dye, FD (90% (v/v) formamide, 15 mM EDTA, 0.05% (w/v) bromophenol blue and 0.05% (w/v) xylene cyanol), and subsequently separated on a 6% denaturing polyacrylamide gel. The RNA was electrotransferred onto Amersham hybond nylon membranes at 20 V for 15 hours. Transfer was performed in a BIORAD blotting chamber in TBE buffer (89 mM Tris, 89 mM boric acid, 0.49 mM EDTA, pH 8.3) at 4°C. Subsequently, the RNA was bound to the membrane by UV-crosslinking. Prehybridization was carried out for two to four hours at 42°C in 15 ml of prehybridization buffer (5 × SSC, 5 × Denhardt, 50% formamide, 50 mM sodium phosphate at pH 6.7, 0.1% (w/v) SDS, 1% (w/v) dextran sulfate and 0.3 mg/ml salmon sperm DNA). Hybridization was performed overnight at 42°C in the same buffer lacking salmon sperm DNA but containing 1 × 10 6 cpm/ ml of labelled probe ([a-
32 P]UTP-labelled RNAII or RNAIII synthesized as described (Brantl & Wagner, 1994) ). Membranes were washed twice for 20 minutes at 42°C in 2 × SSC, 0.5% SDS. Signals were quantified in a Fuji PhosphorImager and subsequently membranes were autoradiographed. Wet membranes were stored at −20°C to allow reprobing. Removal of labelled probe was done by boiling (ten minutes in 1% SDS) followed by prehybridization. To correct for loading errors, reprobing was carried out with the [g 32 P]ATP-labelled oligonucleotide C767-27 (5'GGG TGT GAC CTC TTC GCT ATC GCC ACC) that is complementary to B. subtilis 5 S rRNA; both prehybridization and hybridization were performed at 42°C in 6 × SSC, 3 × Denhardt, and 0.5% SDS (probe: 3 × 10 5 cpm/ml of C767-27). Filters were washed and quantified as described above. All Northern blot analyses and subsequent calculations were performed at least twice on total RNA isolated independently from different cultures.
Lysate ribonuclease protection assay
A lysate ribonuclease protection kit (Amersham) was used to analyze the steady-state concentration of RNAIIF. A 168 nt [a-32 P]UTP-labelled antisense RNA (RNAIII168) complementary to 148 bp of the internal region of repR (nt 646 to 794), but carrying 20 non-complementary nucleotides at its 3' end, was synthesized in vitro with T7 polymerase as described above and purified from a 6% denaturing polyacrylamide gel. The transcription template was generated by PCR on pUC119-F with primers C1122-40 (5'GAA ATT AAT ACG ACT CAC TAT AGG GAA GTC AGA ACA ACG CCA C) and C1123-43 (5'GTA ACT CCC GGG AAC TTA TGC TGT GCT TCA TGA CGG CTT G). Total RNA isolated from 1.5 ml of DB104(pPR1) or DB104(pCOP4) was hybridized with 10 5 cpm of RNAIII168 for two hours and 15 minutes at 42°C in 10 ml of buffer (80% formamide, 50 nM Pipes (pH 6.0), and 0.4 M NaCl), subsequently digested with the ribonuclease mix for 30 minutes at 37°C and, after addition of 20 ml of 10% SDS, precipitated with isopropanol. Reaction products were dissolved, denatured in 5 ml of FD, and separated on a 6% sequencing gel. As a standard for
